Amicus Therapeutics (FOLD) Shares Issued (2016 - 2025)
Historic Shares Issued for Amicus Therapeutics (FOLD) over the last 17 years, with Q3 2025 value amounting to $339000.0.
- Amicus Therapeutics' Shares Issued fell 9771.5% to $339000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$11.0 million, marking a year-over-year decrease of 15076.83%. This contributed to the annual value of $7.7 million for FY2024, which is 2524.27% down from last year.
- Per Amicus Therapeutics' latest filing, its Shares Issued stood at $339000.0 for Q3 2025, which was down 9771.5% from $40000.0 recorded in Q2 2025.
- In the past 5 years, Amicus Therapeutics' Shares Issued ranged from a high of $19.2 million in Q1 2021 and a low of -$11.5 million during Q4 2024
- Over the past 5 years, Amicus Therapeutics' median Shares Issued value was $1.1 million (recorded in 2022), while the average stood at $2.5 million.
- In the last 5 years, Amicus Therapeutics' Shares Issued skyrocketed by 323000.0% in 2022 and then tumbled by 56689.77% in 2024.
- Quarter analysis of 5 years shows Amicus Therapeutics' Shares Issued stood at $30000.0 in 2021, then skyrocketed by 3630.0% to $1.1 million in 2022, then skyrocketed by 119.21% to $2.5 million in 2023, then plummeted by 566.9% to -$11.5 million in 2024, then surged by 102.96% to $339000.0 in 2025.
- Its Shares Issued stands at $339000.0 for Q3 2025, versus $40000.0 for Q2 2025 and $105000.0 for Q1 2025.